Low-Dose Naltrexone (LDN) Research Guide

Full name: Low-Dose Naltrexone

At 1-4.5mg (vs standard 50mg), naltrexone briefly blocks opioid receptors, causing a rebound upregulation of endorphins and enkephalins. Widely prescribed by telemedicine clinics for autoimmune conditions, chronic pain, and inflammation.

How Low-Dose Naltrexone (LDN) Works

Brief nocturnal opioid receptor blockade triggers compensatory upregulation of endogenous opioid production and OGF (opioid growth factor), modulating immune cell proliferation and reducing inflammatory cytokines.

Dosing Protocol

• Typical dose: 1.5-4.5 mg
• Frequency: Nightly at bedtime
• Duration: Ongoing
• Route: Oral capsule (compounded)

Reported Benefits

• Immune modulation
• Reduced inflammation
• Chronic pain relief
• Autoimmune support
• Improved mood via endorphins
• Weight loss support

Potential Side Effects

• Vivid dreams
• Initial sleep disruption
• Mild headache
• Nausea (first week)
• Temporary pain increase

Research Citations

1. LDN in autoimmune disease management (2022) - Reduced inflammatory markers by 40% and improved quality of life scores in fibromyalgia and Hashimoto patients.
2. LDN for chronic pain syndromes (2021) - Achieved 30% pain reduction in 65% of chronic pain patients with minimal side effects vs conventional opioid therapy.

Related Pain & Inflammation Compounds

• PEA - Full Profile
• Diclofenac Topical - Full Profile
• Pentosan (Joint Pain) - Full Profile
• ARA-290 - Full Profile
• Boswellia (AKBA) - Full Profile
• Cartalax - Full Profile

View full Low-Dose Naltrexone (LDN) profile with 3D molecule viewer →